Ajooni Biotech trading near 52-week high; to benefit from strategic agreement with IFFCO Kisan Sanchar

Company will have to create a nationwide logistic network to execute the orders through the already established dealer and distributor network of IKSL

Ajooni Biotech (ABL), a pioneer and leader in the production of animal feed, and IFFCO KISAN Sanchar Ltd (IKSL) have entered into a strategic and exclusive agreement, whereby ABL would manufacture Feed Supplements for IKSL on a pan India basis. This strategic arrangement would diversify ABL products stream from mere cattle feeds business towards high-value supplement business. The company will have to set up a new state-of-the-art manufacturing facility to cater to the supplies of IKSL.

This agreement has helped the company to gain by 13 per cent in the last trading session and is up by more than 80 per cent in last one year. Investors who entered the stock one year back would have seen their investment doubling.  

 Also, the company will have to create a nationwide logistic network to execute the orders through the already established dealer and distributor network of IKSL. Also, the company is in the advanced stage of Research for the Development of new animal health care products i.e Mineral Mixhire, Liver tonic, and other unique products of Veterinary supplements, and will be launched jointly with IKSL in the market within the next few months. The company’s priorities are quality, safety, innovations in the production process, as well as excellent services provided to customers.